Early infections of Toxoplasma gondii and the later development of schizophrenia

Schizophrenia Bulletin

Volumn 33, Issue 3, 2007, Pages 741-744

  Mortensen, Preben Bo ^a   Nørgaard Pedersen, Bent ^b   Waltoft, Berit L ^a   Sørensen, Tina L ^b   Hougaard, David ^b   Yolken, Robert H ^c  

^a AARHUS UNIVERSITY   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Biobank; Birth cohort; Nested case control study

Indexed keywords

IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ANTIBODY PRODUCTION; ARTICLE; BIRTH; BRAIN DEVELOPMENT; DISEASE COURSE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PREGNANCY; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; SCHIZOPHRENIA; SERUM; TOXOPLASMA GONDII; ADULT; ANIMAL; BLOOD; BRAIN; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; CONGENITAL TOXOPLASMOSIS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; IMMUNOLOGY; MALE; NEWBORN; PARASITOLOGY; PATHOPHYSIOLOGY; PRENATAL EXPOSURE; PSYCHOLOGY; TOXOPLASMA; TOXOPLASMOSIS;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; BRAIN; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TOXOPLASMA; TOXOPLASMOSIS, CEREBRAL; TOXOPLASMOSIS, CONGENITAL;

EID: 34548024413     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm009     Document Type: Article

References (24)

1. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res. 2004;71:405-416.
2. Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004;61:774-780.
3. Mednick SA, Machon RA, Huttunen MD, Bonnett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988;45:189-192.
4. Barr CE, Mednick SA, Munk Jorgensen P. Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study. Arch Gen Psychiatry. 1990;47:869-874.
5. Suvisaari J, Haukka J, Tanskanen A, Hovi T, Lonnqvist J. Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry. 1999;156:1100-1102.
6. Torrey EF, Rawlings R, Waldman IN. Schizophrenic births and viral diseases in two states. Schizophr Res. 1988;1:73-77.
7. Brown AS, Cohen P, Harkavy-Friedman J, et al. A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry. 2001;49:473-486.
8. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry. 2001;58:1032-1037.
9. Koponen H, Rantakallio P, Veijola J, Jones P, Jokelainen J, Isohanni M. Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:9-13.
10. Babulas V, Factor-Litvak P, Goetz R, Schaefer CA, Brown AS. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry. 2006;163:927-929.
11. Yolken RH, Torrey EF. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev. 1995;8:131-145.
12. Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry. 2005;162:767-773.
13. Mortensen PB, Pedersen BN, Waltoft BL, et al. Toxoplasma gondii as a risk factor for schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry. In press.
14. Wilson M, McAuley JB. Toxoplasma. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. Washington, DC: ASM Press; 1999: 1374-1382.
15. Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet. 1999;353:1834-1837.
16. Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 2006;33:270-298.
17. Sakic B, Kirkham DL, Ballok DA, et al. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J Neuroimmunol. 2005;169:68-85.
18. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001;7:1189-1193.
19. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci USA. 2006;103:678-683.
20. Kosugi I, Kawasaki H, Tsuchida T, Tsutsui Y. Cytomegalovirus infection inhibits the expression of N-methyl-D-aspartate receptors in the developing mouse hippocampus and primary neuronal cultures. Acta Neuropathol (Berl). 2005;109:475-482.
21. Herlenius E, Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp Neurol. 2004;190 Suppl 1:S8-S21.
22. Stibbs HH. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol. 1985;79:153-157.
23. Mueller N, Schwarz MJ. Immunology in schizophrenic disorders. Nervenarzt. In press.
24. Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case-control study of selected risk factors. Schizophr Res. 2000;46:17-23.